Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 31.41 CNY -0.44% Market Closed
Market Cap: 46.7B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Gross Margin
Pharmaron Beijing Co Ltd

33.4%
Current
36%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
33.4%
=
Gross Profit
3.8B
/
Revenue
11.5B

Gross Margin Across Competitors

Country CN
Market Cap 46.7B CNY
Gross Margin
33%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 207.5B USD
Gross Margin
41%
Country US
Market Cap 173.4B USD
Gross Margin
60%
Country KR
Market Cap 70.2T KRW
Gross Margin
50%
Country CH
Market Cap 40.8B CHF
Gross Margin
29%
Country US
Market Cap 39.2B USD
Gross Margin
35%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Country US
Market Cap 26.5B USD
Gross Margin
59%
Country US
Market Cap 23.7B USD
Gross Margin
64%
Country US
Market Cap 23.6B USD
Gross Margin
35%

Profitability Report

View the profitability report to see the full profitability analysis for Pharmaron Beijing Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
33.4%
=
Gross Profit
3.8B
/
Revenue
11.5B
What is the Gross Margin of Pharmaron Beijing Co Ltd?

Based on Pharmaron Beijing Co Ltd's most recent financial statements, the company has Gross Margin of 33.4%.